SAB Biotherapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of SAB Biotherapeutics generated cash of -$25,119,405, which is less than the previous year. Cash used in financing activities reached the amount of $66,773,137 last year. Net change in cash is therefore $41,519,172.
Cash Flow
| 2019 | -9.21M | -608.74K | 3.68M |
|---|---|---|---|
| 2020 | 10.00M | -12.72M | 8.98M |
| 2021 | 3.75M | -10.94M | 34.11M |
| 2022 | 3.75M | -10.94M | 34.11M |
| 2023 | -25.11M | -152.70K | 66.77M |
SABSW Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 15.04M | 12.61M | 12.61M | 6.34M | 12.48M |
Operating activities | |||||
Net income | -42.19M | -17.14M | -17.14M | 20.11M | -8.98M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 3.74M | 1.65M | 1.65M | 548.17K | 323.40K |
Stock-based compensation expense | 2.42M | 2.67M | 2.31M | 1.29M | 371.38K |
| Deferred income tax benefit | 2.42M | 2.67M | 2.31M | 1.29M | 371.38K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 5.55M | 12.55M | 12.55M | -17.75M | -2.56M |
Inventories | 0 | 0 | 0 | 484.84K | 0 |
Accounts payable | -2.70M | -2.93M | -2.93M | 5.21M | 1.55M |
Cash generated by operating activities | -25.11M | 3.75M | 3.75M | 10.00M | -9.21M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -197.15K | -10.94M | -10.94M | -12.73M | -608.74K |
Acquisitions Net | 0 | 76.39K | 0 | 9K | 0 |
Cash generated by investing activities | -152.70K | -10.94M | -10.94M | -12.72M | -608.74K |
Financing activities | |||||
Common Stock Issued | 67.16M | 7.68M | 6.75K | 9.90M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -5.52M | 0 | 0 | 0 |
Repayments of term debt | -390.44K | -1.18M | -227.26K | -1.57M | 0 |
Cash used in financing activities | 66.77M | 34.11M | 34.11M | 8.98M | 3.68M |
Net Change In Cash | 41.51M | 26.93M | 26.93M | 6.26M | -6.14M |
Cash at end of period | 56.56M | 39.54M | 39.54M | 12.61M | 6.34M |
| Data source | Data source | Data source | Data source |